Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-14

Clinical Trial Update: Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission [Phase 2]

View source ↗

Summary

Phase 2 trial update showing that Carraguard (PC-515) is safe and acceptable, with preliminary effectiveness data in preventing HIV and other sexually transmitt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carraguard

Snippet

Sponsor: Population Council | Conditions: HIV Infections, Chlamydia Trachomatis | Phase 2 | Status: COMPLETED